Skip to main content
Erschienen in: International Journal of Diabetes in Developing Countries 4/2017

24.08.2016 | Original Article

Zymogram profiling of myeloperoxidase in association with increased risk of infection susceptibility in diabetic foot ulcer

verfasst von: Saumya Mary Mathew, T. V. Suchithra

Erschienen in: International Journal of Diabetes in Developing Countries | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

An increase in blood glucose level can lead to altered immunological response of the body and increased infection susceptibility in diabetic condition. This condition along with the variation in the oxidant-antioxidant status can further lead to impaired wound healing. Myeloperoxidase (MPO) is one of the key enzymes involved in oxidative stress and phagocytosis. The main focus of this study was on the prevalence of isozymes of MPO in diabetic foot ulcer condition. Prior to the zymogram studies, the variations in leukocyte MPO activity in diabetic patients with and without foot infection were analysed. The MPO activity in diabetic foot ulcer patients was elevated than that of diabetic patients without foot ulcer complications, but the levels were not up to the MPO levels of the controls. The difference in banding pattern was observed in native PAGE analysis of MPO enzyme isolated from diabetic foot ulcer patients compared to diabetic and non-diabetic control groups. The multiple isozymic bands observed in diabetic foot ulcer condition were unique from that of diabetic patients without complication and normal healthy individuals.
Literatur
1.
Zurück zum Zitat Arnhold J. Properties, functions, and secretion of human myeloperoxidase. Biochemistry Biokhimiia. 2004;69(1):4–9.CrossRefPubMed Arnhold J. Properties, functions, and secretion of human myeloperoxidase. Biochemistry Biokhimiia. 2004;69(1):4–9.CrossRefPubMed
2.
Zurück zum Zitat Matheson NR, Wong PS, Travis J. Isolation and properties of human neutrophil myeloperoxidase. Biochemistry. 1981;20(2):325–30.CrossRefPubMed Matheson NR, Wong PS, Travis J. Isolation and properties of human neutrophil myeloperoxidase. Biochemistry. 1981;20(2):325–30.CrossRefPubMed
3.
Zurück zum Zitat Marchetti C, Patriarca P, Solero GP, Baralle FE, Romano M. Genetic characterization of myeloperoxidase deficiency in Italy. Hum Mutat. 2004;23(5):496–505.CrossRefPubMed Marchetti C, Patriarca P, Solero GP, Baralle FE, Romano M. Genetic characterization of myeloperoxidase deficiency in Italy. Hum Mutat. 2004;23(5):496–505.CrossRefPubMed
4.
Zurück zum Zitat Kutter D, Devaquet P, Vanderstocken G, Paulus JM, Marchal V, Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol. 2000;104(1):10–5.CrossRefPubMed Kutter D, Devaquet P, Vanderstocken G, Paulus JM, Marchal V, Gothot A. Consequences of total and subtotal myeloperoxidase deficiency: risk or benefit? Acta Haematol. 2000;104(1):10–5.CrossRefPubMed
5.
Zurück zum Zitat Unubol M, Yavasoglu I, Kacar F, Guney E, Omurlu IK, Ture M, Kadikoylu G, Bolaman Z. Relationship between glycemic control and histochemical myeloperoxidase activity in neutrophils in patients with type 2 diabetes. Diabetol Metab Syndr. 2015;7(1):1–7.CrossRef Unubol M, Yavasoglu I, Kacar F, Guney E, Omurlu IK, Ture M, Kadikoylu G, Bolaman Z. Relationship between glycemic control and histochemical myeloperoxidase activity in neutrophils in patients with type 2 diabetes. Diabetol Metab Syndr. 2015;7(1):1–7.CrossRef
6.
Zurück zum Zitat Klebanoff SJ, Kettle AJ, Rosen H, Winterbourn CC, Nauseef WM. Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J Leukoc Biol. 2013;93(2):185–98.CrossRefPubMedPubMedCentral Klebanoff SJ, Kettle AJ, Rosen H, Winterbourn CC, Nauseef WM. Myeloperoxidase: a front-line defender against phagocytosed microorganisms. J Leukoc Biol. 2013;93(2):185–98.CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Miller LS, Cho JS. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol. 2011;11(8):505–18.CrossRefPubMed Miller LS, Cho JS. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol. 2011;11(8):505–18.CrossRefPubMed
8.
Zurück zum Zitat Cech P, Stalder H, Widmann JJ, Rohner A, Miescher PA. Leukocyte myeloperoxidase deficiency and diabetes mellitus associated with Candida albicans liver abscess. Am J Med. 1979;66(1):149–53.CrossRefPubMed Cech P, Stalder H, Widmann JJ, Rohner A, Miescher PA. Leukocyte myeloperoxidase deficiency and diabetes mellitus associated with Candida albicans liver abscess. Am J Med. 1979;66(1):149–53.CrossRefPubMed
9.
Zurück zum Zitat Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78(3):206–9.CrossRefPubMed Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol. 1982;78(3):206–9.CrossRefPubMed
10.
11.
Zurück zum Zitat Pendsey S. Understanding diabetic foot. Int J Diab Dev Ctries. 2010;30(2):75–9.CrossRef Pendsey S. Understanding diabetic foot. Int J Diab Dev Ctries. 2010;30(2):75–9.CrossRef
12.
Zurück zum Zitat American Diabetes A. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Suppl 1):S14–80.CrossRef American Diabetes A. Standards of medical care in diabetes—2014. Diabetes Care. 2014;37(Suppl 1):S14–80.CrossRef
13.
Zurück zum Zitat Taketa K. A tetrazolium method for peroxidase staining: application to the antibody-affinity blotting of α-fetoprotein separated by lectin affinity electrophoresis. Electrophoresis. 1987;8(9):409–14.CrossRef Taketa K. A tetrazolium method for peroxidase staining: application to the antibody-affinity blotting of α-fetoprotein separated by lectin affinity electrophoresis. Electrophoresis. 1987;8(9):409–14.CrossRef
14.
Zurück zum Zitat Strauven TA, Armstrong D, James GT, Austin JH. Separation of leukocyte peroxidase isoenzymes by agarose-acrylamide disc electrophoresis. Age. 1978;1(3):111–6.CrossRef Strauven TA, Armstrong D, James GT, Austin JH. Separation of leukocyte peroxidase isoenzymes by agarose-acrylamide disc electrophoresis. Age. 1978;1(3):111–6.CrossRef
15.
Zurück zum Zitat Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med. 2000;28(12):1717–25.CrossRefPubMed Podrez EA, Abu-Soud HM, Hazen SL. Myeloperoxidase-generated oxidants and atherosclerosis. Free Radic Biol Med. 2000;28(12):1717–25.CrossRefPubMed
16.
Zurück zum Zitat Park YJ, Park G, Lee SH, Jang SJ, Moon DS, Park CY, Chung CH, Cha JH, Lee BR, Choi YH. Myeloperoxidase (MPO) isozymes of normal neutrophils from normal persons and reactive neutrophils from patients with neutrophilia; using 10 % native PAGE and activity stain for MPO. The Korean Journal of Hematology. 2003;38(1):48–54. Park YJ, Park G, Lee SH, Jang SJ, Moon DS, Park CY, Chung CH, Cha JH, Lee BR, Choi YH. Myeloperoxidase (MPO) isozymes of normal neutrophils from normal persons and reactive neutrophils from patients with neutrophilia; using 10 % native PAGE and activity stain for MPO. The Korean Journal of Hematology. 2003;38(1):48–54.
17.
Zurück zum Zitat Loria V, Dato I, Graziani F, Biasucci LM. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediat Inflamm. 2008;2008:135625.CrossRef Loria V, Dato I, Graziani F, Biasucci LM. Myeloperoxidase: a new biomarker of inflammation in ischemic heart disease and acute coronary syndromes. Mediat Inflamm. 2008;2008:135625.CrossRef
18.
Zurück zum Zitat Uchimura K, Nagasaka A, Hayashi R, Makino M, Nagata M, Kakizawa H, Kobayashi T, Fujiwara K, Kato T, Iwase K, et al. Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus. J Diabetes Complicat. 1999;13(5–6):264–70.CrossRefPubMed Uchimura K, Nagasaka A, Hayashi R, Makino M, Nagata M, Kakizawa H, Kobayashi T, Fujiwara K, Kato T, Iwase K, et al. Changes in superoxide dismutase activities and concentrations and myeloperoxidase activities in leukocytes from patients with diabetes mellitus. J Diabetes Complicat. 1999;13(5–6):264–70.CrossRefPubMed
19.
Zurück zum Zitat Suchithra TV, Zuhara KF. Myeloperoxidase activity in infection complicated and uninfected diabetic patients. Ind J Biochem Biophys. 2008;45(3):179–83. Suchithra TV, Zuhara KF. Myeloperoxidase activity in infection complicated and uninfected diabetic patients. Ind J Biochem Biophys. 2008;45(3):179–83.
20.
Zurück zum Zitat Paumann-Page M, Furtmuller PG, Hofbauer S, Paton LN, Obinger C, Kettle AJ. Inactivation of human myeloperoxidase by hydrogen peroxide. Arch Biochem Biophys. 2013;539(1):51–62.CrossRefPubMedPubMedCentral Paumann-Page M, Furtmuller PG, Hofbauer S, Paton LN, Obinger C, Kettle AJ. Inactivation of human myeloperoxidase by hydrogen peroxide. Arch Biochem Biophys. 2013;539(1):51–62.CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Nauseef WM, McCormick SJ, Clark RA. Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J Biol Chem. 1995;270(9):4741–7.CrossRefPubMed Nauseef WM, McCormick SJ, Clark RA. Calreticulin functions as a molecular chaperone in the biosynthesis of myeloperoxidase. J Biol Chem. 1995;270(9):4741–7.CrossRefPubMed
22.
Zurück zum Zitat Raven E, Dunford B: Chapter 12. Myeloperoxidase: structure and function of the green heme peroxidase of neutrophils. In: Heme Peroxidases. Royal Society of Chemistry; 2015: 272–308. Raven E, Dunford B: Chapter 12. Myeloperoxidase: structure and function of the green heme peroxidase of neutrophils. In: Heme Peroxidases. Royal Society of Chemistry; 2015: 272–308.
23.
Zurück zum Zitat Otto NM, Schindler R, Lun A, Boenisch O, Frei U, Oppert M. Hyperosmotic stress enhances cytokine production and decreases phagocytosis in vitro. Crit Care. 2008;12(4):R107.CrossRefPubMedPubMedCentral Otto NM, Schindler R, Lun A, Boenisch O, Frei U, Oppert M. Hyperosmotic stress enhances cytokine production and decreases phagocytosis in vitro. Crit Care. 2008;12(4):R107.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Jafar N, Edriss H, Nugent K. The effect of short-term hyperglycemia on the innate immune system. Am J Med Sci. 2016;351(2):201–11.CrossRefPubMed Jafar N, Edriss H, Nugent K. The effect of short-term hyperglycemia on the innate immune system. Am J Med Sci. 2016;351(2):201–11.CrossRefPubMed
Metadaten
Titel
Zymogram profiling of myeloperoxidase in association with increased risk of infection susceptibility in diabetic foot ulcer
verfasst von
Saumya Mary Mathew
T. V. Suchithra
Publikationsdatum
24.08.2016
Verlag
Springer India
Erschienen in
International Journal of Diabetes in Developing Countries / Ausgabe 4/2017
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-016-0518-1

Weitere Artikel der Ausgabe 4/2017

International Journal of Diabetes in Developing Countries 4/2017 Zur Ausgabe